BioAsia
BioAsia Biotech CO., LTD (referred to as "BioAsia") was founded through the initiative of the Shanghai BioAsia Group and was restructured and established in 2010. BioAsia leverages microbial resources (with a particular focus on entomopathogenic fungi) as its foundation and synthetic biology as its core driver. BioAsia is dedicated to the multi-dimensional application of entomopathogenic fungi, conducting systematic research, industrial transformation, and international expansion across the entire value chain and in all dimensions.
Our R&D and industrial bases are located in Pinghu, Zhejiang (Headquarters), Huai'an, Jiangsu, Shanghai, and Eskilstuna, Sweden. The Group's subsidiaries include Zhejiang BioAsia Health Food Co., Ltd., Shanghai BioAsia Bio-Engineering Technology Co., Ltd., Jiangsu BioAsia CordyFarm, Plantamed AB (a Swedish botanical pharmaceuticals company), the Zhejiang BioAsia Life Science Research Institute, the Cordyseum, and the Microbe Science Museum. BioAsia owns an advanced microbial strain bank and a solid-state biotech fermentation center, forging outstanding quality through technological innovation and guarding human health with a spirit of craftsmanship.
China Patent Gold Award
Chanhua (Cordyceps cicadae) Biological Cultivation Technology Awarded the "China Patent Gold Award"
Novel Food Ingredient
In 2021, the artificially cultivated fruiting bodies of Chanhua (Cordyceps cicadae), originally developed by BioAsia, were approved by the Chinese government as a "Novel Food Ingredient."